| Functional proteomic screen identifies a modulating role for CD44 in death receptor-mediated apoptosis. | |
| | |
MedLine Citation:
|
PMID: 15753387 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Apoptotic evasion is a hallmark of cancer and its resistance to chemotherapeutic drugs. Identification of cellular proteins that mediate apoptotic programs is a critical step toward the development of therapeutics aimed at overcoming apoptosis resistance. We developed an innovative high-throughput screen to identify proteins that modulate Fas ligand-mediated apoptosis using fluorophore-assisted light inactivation (HTS-FALIpop). The FALI protein knockdown strategy was coupled to a caspase activity assay with the ability to detect both proapoptotic and antiapoptotic surface molecules expressed by HT-1080 human fibrosarcoma cells. FALI of the Fas receptor (Fas/CD95) using a fluorescein-conjugated anti-Fas antibody abrogated Fas ligand-mediated caspase activation. Ninety-six single-chain variable fragment antibodies (scFv), selected for binding to the surface of HT-1080 cells, were screened by HTS-FALIpop. Three of the scFvs caused decreases in caspase induction after FALI of their protein targets. One of the targets of these positive scFvs was identified as CD44 and was validated by performing FALI using a CD44-specific monoclonal antibody, which resulted in similar protection from Fas apoptosis. CD44-targeted FALI was antiapoptotic in multiple human cancer cell lines, including both Fas signaling type I and II cells, and was also protective against other ligands of the tumor necrosis factor death receptor family. FALI of CD44 inhibited formation and activation of the death-inducing signaling complex, suggesting that CD44 regulates Fas at the cell surface. This mechanism of death receptor regulation represents a novel means of apoptosis modulation that could be exploited by pharmacologic agents. |
| | |
Authors:
|
Robert S Hauptschein; Kevin E Sloan; Claudia Torella; Roya Moezzifard; Maryann Giel-Moloney; Carol Zehetmeier; Christine Unger; Leodevico L Ilag; Daniel G Jay |
Related Documents
:
|
17544837 - Requirement of n-glycosylation for the secretion of recombinant extracellular domain of... 11870367 - Cox-2 inhibits fas-mediated apoptosis in cholangiocarcinoma cells. 10704237 - Transient apoptosis elicited by insulin in serum-starved glioma cells involves fas/fas-... 11282997 - Apoptosis induced by the antigen receptor and fas in a variant of the immature b cell l... 23452257 - Differential effects of cxcr4-cxcl12- and cxcr7-cxcl12-mediated immune reactions on mur... 11747597 - Construction of single-chain interleukin-12 dna plasmid to treat airway hyperresponsive... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Cancer research Volume: 65 ISSN: 0008-5472 ISO Abbreviation: Cancer Res. Publication Date: 2005 Mar |
Date Detail:
|
Created Date: 2005-03-08 Completed Date: 2005-04-19 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 2984705R Medline TA: Cancer Res Country: United States |
Other Details:
|
Languages: eng Pagination: 1887-96 Citation Subset: IM |
Affiliation:
|
Department of Physiology, Tufts University School of Medicine, Boston, Massachusetts 02111, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antigens, CD44 / genetics, metabolism* Antigens, CD95 / genetics, metabolism* Apoptosis* Carcinoma, Renal Cell / metabolism, pathology Caspases / metabolism Death Domain Receptor Signaling Adaptor Proteins Enzyme Activation Fibrosarcoma / metabolism, pathology Humans Immunoglobulin Fragments / immunology* Kidney Neoplasms / metabolism, pathology Lymphoma, T-Cell / metabolism, pathology Mammary Neoplasms, Experimental / metabolism, pathology Mass Spectrometry Mice Proteomics* Receptors, Tumor Necrosis Factor / metabolism* Tumor Cells, Cultured |
| Grant Support | |
ID/Acronym/Agency:
|
CA-81668/CA/NCI NIH HHS; DK-07542/DK/NIDDK NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD44; 0/Antigens, CD95; 0/Death Domain Receptor Signaling Adaptor Proteins; 0/Immunoglobulin Fragments; 0/Receptors, Tumor Necrosis Factor; EC 3.4.22.-/Caspases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Activin A suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechani...
Next Document: Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.